Holdings (as at 2025-02-14)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Doximity, Inc. (Class A) 3.09%
Royalty Pharma Plc (Class A) 2.71%
Intra-Cellular Therapies, Inc. 2.62%
Natera, Inc. 2.34%
Jazz Pharmaceuticals Plc 2.33%
Cardinal Health, Inc. 2.28%
Tenet Healthcare Corporation 2.26%
Exelixis, Inc. 2.25%
United Therapeutics Corporation 2.24%
Acadia Healthcare Company, Inc. 2.22%
Universal Health Services, Inc. (Class B) 2.16%
Centene Corporation 2.01%
Elanco Animal Health Incorporated 1.99%
Intuitive Surgical, Inc. 1.95%
Penumbra, Inc. 1.94%
Biogen Inc. 1.92%
Quest Diagnostics Incorporated 1.91%
Roivant Sciences Ltd. 1.91%
Masimo Corporation 1.88%
Insulet Corporation 1.84%
Elevance Health Inc. 1.81%
DaVita Inc. 1.80%
Premier, Inc. (Class A) 1.79%
Organon & Co. 1.75%
Zimmer Biomet Holdings, Inc. 1.63%
Regeneron Pharmaceuticals, Inc. 1.62%
Molina Healthcare, Inc. 1.60%
Hologic, Inc. 1.50%
Medtronic Plc 1.49%
Viatris Inc. 1.48%
Veeva Systems Inc. (Class A) 1.43%
Henry Schein, Inc. 1.41%
Charles River Laboratories International, Inc. 1.41%
Encompass Health Corporation 1.40%
Johnson & Johnson 1.39%
Stryker Corporation 1.37%
The Cigna Group 1.36%
HCA Healthcare, Inc. 1.35%
Chemed Corporation 1.34%
Incyte Corporation 1.31%
ResMed Inc. 1.31%
Humana Inc. 1.29%
Pfizer Inc. 1.23%
Teleflex Incorporated 1.21%
Neurocrine Biosciences, Inc. 1.08%
GE HealthCare Technologies Inc. 1.01%
Abbott Laboratories 0.99%
Labcorp Holdings Inc. 0.92%
UnitedHealth Group Incorporated 0.88%
Thermo Fisher Scientific Inc. 0.88%
Edwards Lifesciences Corporation 0.88%
Agilent Technologies, Inc. 0.86%
Revvity, Inc. 0.86%
Enovis Corporation 0.86%
Inspire Medical Systems, Inc. 0.86%
Becton, Dickinson and Company 0.85%
Waters Corporation 0.85%
IQVIA Holdings Inc. 0.84%
Perrigo Company Plc 0.82%
Sarepta Therapeutics, Inc. 0.76%
DexCom, Inc. 0.46%
Eli Lilly and Company 0.44%
Alnylam Pharmaceuticals, Inc. 0.44%
Steris Plc 0.43%
Baxter International Inc. 0.42%
Medpace Holdings, Inc. 0.41%
BioMarin Pharmaceutical Inc. 0.40%
Align Technology, Inc. 0.40%
Zoetis Inc. 0.39%
The Cooper Companies, Inc. 0.38%
Danaher Corporation 0.36%
Exact Sciences Corporation 0.35%
Bruker Corporation 0.34%
Apellis Pharmaceuticals, Inc. 0.34%
Avantor, Inc. 0.34%
West Pharmaceutical Services, Inc. 0.26%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.